Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford University and the Chinese Academy of Medical Sciences (CAMS) signed a cooperation agreement at a virtual unveiling ceremony of the CAMS Oxford Institute.

CAMS Oxford Institute virtual signing ceremony

The Vice-Chancellor of the University of Oxford formally unveiled the CAMS Oxford Institute (COI), a joint institute base in Oxford and supported by Oxford University and Chinese Academy of Medical Sciences/Peking Union Medical school.

The Institute will deliver outstanding science and help to develop innovative medicines to tackle infectious diseases and cancer.

The virtual event, hosted by The Nuffield Department of Medicine, on Oxford’s Old Road Campus, on Thursday 28th April, was attended by Chen Wang (President of CAMS/PUMC), Zeguang Zheng (Chinese Ambassador, Chinese Embassy London), Jianxue Sheng (Secretary General of China scholarship Council) and Xuetao Cao (President of Nankai University and Co-Director of COI).

In September 2016 Professor Richardson visited China and met with Bin Li, Minister of Chinese National Health and Family Planning Commission, to discuss the establishment of the COI. The MOU was subsequently signed during the visit of Madam Yandong Liu (Vice Premier of China) to the UK in December 2017. The final official research agreement was signed in April 2019 by President Chen Wang of CAMS/PUMC, and Professor Gavin Screaton Head of Medical Sciences Division in Oxford. The COI was up running at the beginning of 2019, and it was China’s first overseas medical sciences institute in the UK.

Professor Louise Richardson, Vice-Chancellor of the University of Oxford, said: ‘Since the foundation of the COI it has grown quickly to play an ever more important role in health research. Today’s cooperation agreement will lay the ground for continued growth of this important research institute. It is fitting that in this, the 50th anniversary year of the establishment of ambassadorial diplomatic relations between China and UK, we continue to recognize the importance of our international research collaborations in medical sciences.’

Professor Chen Wang, President of CAMS/PUMC, said: ‘COI is a vivid showcase of successful cooperation paradigm of the two countries. It lays a solid foundation as an iconic base for global collaboration. Looking ahead, CAMS/PUMC and University of Oxford will further engage in joint efforts to promote well-being for humanity by achieving ‘One Health’ and contribute to the building of a global community of health for all.’

CAMS Oxford Institute virtual signing ceremonyCAMS Oxford Institute virtual signing ceremonyIn collaboration with the China Scholarship Council (CSC) through “CSC-CAMS/PUMC- Oxford High-level Innovative Talent Scholarships” Program and China scholarship Council/Nuffield Department of Medicine matching funding scheme, the COI has facilitated more than 30 DPhil students working with PIs across the Medical Sciences Division. The program has been extremely popular, and the University hopes to continue this collaboration with the China Scholarship Council and work together to train the next generation of scientists and to strengthen the link and collaborative effort to tackle many global health issues.

Similar stories

Leedham Lab receives funding to improve bowel cancer treatments

The Leedham Lab at the Wellcome Centre for Human Genetics in the Nuffield Department of Medicine (NDM) has been awarded over £2m from Cancer Research UK to develop a new tool that could help guide how bowel cancer patients are treated in the future.

Oxford’s Ebola vaccine recommended for deployment against Uganda outbreak

A vaccine developed by the Oxford Vaccine Group’s Prof Teresa Lambe and supported in clinical trials and manufacture scale-up by researchers from Nuffield Department of Medicine's Jenner Institute has been recommended for inclusion in a ring vaccination trial to combat a Sudan ebolavirus outbreak in Uganda.

New study provides important insights into TB correlates of protection

Researchers from the Nuffield Department of Medicine’s Jenner Institute have today reported the findings from a study investigating whether previously identified correlates of protection associated with the risk of tuberculosis (TB) disease could also be associated with the risk of infection from the bacteria that causes TB.

Therapeutic HIV vaccine achieves encouraging results

A phase I/IIa clinical trial that the Nuffield Department of Medicine's Jenner Institute collaborated on has demonstrated that a T-cell therapeutic HIV vaccine was associated with better control of the virus rebound when antiretroviral therapy (ART) was temporarily withdrawn.

Prof James Naismith elected as Academy of Medical Sciences' Vice President

Established in 1998, the Academy of Medical Sciences is one of the four UK National Academies, coordinating scholarly research activities and standards in the UK.

Oxford gets £122m funding for healthcare research

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients. The funding was awarded to the two NIHR Biomedical Research Centres.